Use of low-variability methods of treatment in SNPin patients with idiopathic thrombocytopenia

AUTHORS : Vasilkovskaya O.V. | Mkhitaryan K.N.

RELEVANT UNIVERSITIES : Bulgaria, Gabrovo, Clinic “Vitamed-plus”, Gabrovo, Bulgaria; Center “IMEDIS”, Moscow, Russia

YEAR : 2019 | Category : Method of Treatment

Introduction Thrombocytopenia is a pathological condition characterized by a decrease in the number of platelets (red platelets) in the bloodstream to 140,000 / μl and below (normally 150,000–400,000 / μl) [1]. Primary thrombocytopenia, or idiopathic autoimmune thrombocytopenic purpura, is an autoimmune disease characterized by destruction of platelets by autoantibodies. In this case, the production of platelets in the bone marrow is normal or increased. The cause of the pathology is unknown. Distinguish between acute and chronic forms of the course of the disease.

The acute form is typical for children, the chronic form for adults. The duration of the disease in the acute form does not exceed 6 months [1]. The primary idea of thrombocytopenia is formed on the basis of the revealed manifestations of hemorrhagic diathesis of the petechial-spotty type. This is true for thrombocytopenia of any genesis. The idea of thrombocytopenia as the cause of hemorrhagic diathesis is confirmed by the study of the cellular composition of peripheral blood. For the final verification of the diagnosis, a morphological examination of the bone marrow and an immunological study are performed.